Robert F. Werner Twist Bioscience Corp (TWST) insider trading activity

Robert F. Werner is Chief Accounting Officer of Twist Bioscience Corp. Currently has a direct ownership of 51,434 shares of TWST, which is worth approximately $2.01 Million. The most recent transaction as insider was on Mar 06, 2025, when has been sold 241 shares (Common Stock) at a price of $40.91 per share, resulting in proceeds of $9,859. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.4K

3.03% 3M change

17.75% 12M change

Total Value Held $2.01 Million

ROBERT F. WERNER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2025	SELL Open market or private sale	$9,859 $40.91 p/Share	241 Reduced 0.47%	51,434 Common Stock
Feb 24 2025	SELL Open market or private sale	$38,206 $41.71 p/Share	916 Reduced 1.74%	51,675 Common Stock
Feb 21 2025	SELL Open market or private sale	$11,796 $44.18 p/Share	267 Reduced 0.51%	52,591 Common Stock
Feb 03 2025	SELL Open market or private sale	$9,129 $49.35 p/Share	185 Reduced 0.35%	52,858 Common Stock
Dec 06 2024	SELL Open market or private sale	$11,910 $52.7 p/Share	226 Reduced 0.42%	53,043 Common Stock
Dec 04 2024	BUY Grant, award, or other acquisition	-	8,438 Added 13.67%	53,269 Common Stock
Nov 25 2024	SELL Open market or private sale	$34,873 $44.2 p/Share	789 Reduced 1.73%	44,831 Common Stock
Nov 06 2024	SELL Open market or private sale	$64,580 $44.6 p/Share	1,448 Reduced 3.08%	45,620 Common Stock
Nov 04 2024	SELL Open market or private sale	$6,483 $41.56 p/Share	156 Reduced 0.33%	47,068 Common Stock
Nov 04 2024	BUY Grant, award, or other acquisition	-	8,500 Added 15.25%	47,224 Common Stock
Sep 06 2024	SELL Open market or private sale	$9,398 $39.16 p/Share	240 Reduced 0.62%	38,724 Common Stock
Aug 23 2024	SELL Open market or private sale	$35,072 $43.14 p/Share	813 Reduced 2.04%	38,964 Common Stock
Aug 05 2024	SELL Open market or private sale	$6,708 $39.93 p/Share	168 Reduced 0.42%	39,777 Common Stock
Jun 06 2024	SELL Open market or private sale	$12,421 $51.33 p/Share	242 Reduced 0.6%	39,945 Common Stock
May 23 2024	SELL Open market or private sale	$142,237 $42.32 p/Share	3,361 Reduced 7.72%	40,187 Common Stock
May 03 2024	SELL Open market or private sale	$4,901 $37.13 p/Share	132 Reduced 0.3%	43,548 Common Stock
Mar 06 2024	SELL Open market or private sale	$6,774 $37.43 p/Share	181 Reduced 0.41%	43,680 Common Stock
Feb 02 2024	SELL Payment of exercise price or tax liability	$4,427 $36.59 p/Share	121 Reduced 0.28%	43,861 Common Stock
Dec 05 2023	SELL Payment of exercise price or tax liability	$3,725 $24.67 p/Share	151 Reduced 0.34%	43,982 Common Stock
Nov 02 2023	BUY Grant, award, or other acquisition	-	5,633 Added 11.32%	44,133 Common Stock
Sep 05 2023	BUY Grant, award, or other acquisition	-	8,500 Added 18.09%	38,500 Common Stock
May 22 2023	BUY Grant, award, or other acquisition	-	30,000 Added 50.0%	30,000 Common Stock

Also insider at

NVTA

Invitae Corp Healthcare

Chief Accounting Officer

RFW

Robert F. Werner

Chief Accounting Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TWST shares.

Notify only if

Value

Insider Trading

Get notified when an Twist Bioscience Corp insider buys or sells TWST shares.

Notify only if

Operation

Value

Type

News

Receive news related to Twist Bioscience Corp

Track Activities on TWST

Account